The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Open accessAbstract
Inflammasomes activate caspase-1 for processing and secretion of the cytokines interleukin-1beta (IL-1beta) and IL-18. Cryopyrin/NALP3/NLRP3 is an essential component of inflammasomes triggered by microbial ligands, danger-associated molecular patterns (DAMPs), and crystals. Inappropriate Cryopyrin activity has been incriminated in the pathogenesis of gouty arthritis, Alzheimer's, and silicosis. Therefore, inhibitors of the Nalp3 inflammasome offer considerable therapeutic promise. In this study, we show that the type 2 diabetes drug glyburide prevented activation of the Cryopyrin inflammasome. Glyburide's cyclohexylurea group, which binds to adenosine triphosphatase (ATP)-sensitive K(+) (K(ATP)) channels for insulin secretion, is dispensable for inflammasome inhibition. Macrophages lacking K(ATP) subunits or ATP-binding cassette transporters also activate the Cryopyrin inflammasome normally. Glyburide analogues inhibit ATP- but not hypothermia-induced IL-1beta secretion from human monocytes expressing familial cold-associated autoinflammatory syndrome-associated Cryopyrin mutations, thus suggesting that inhibition occurs upstream of Cryopyrin. Concurrent with the role of Cryopyrin in endotoxemia, glyburide significantly delays lipopolysaccharide-induced lethality in mice. Therefore, glyburide is the first identified compound to prevent Cryopyrin activation and microbial ligand-, DAMP-, and crystal-induced IL-1beta secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glyburide is a commonly used sulfonylurea drug for the treatment of type 2 diabetes and was recently shown to inhibit the NLRP-3 inflammasome through a mechanism that appears to be different from that involved in its ability to promote insulin secretion from pancreatic β-cells (38).”
From Sustained Inflammasome Activity in Macrophages Impairs Wound Healing in Type 2 Diabetic Humans and Mice (2014) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Self-citationHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,864
Self-citationHoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,679
Self-citationPannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,490
Cloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
Kanneganti, T., Özören, N., Body–Malapel, M., Amer, A. O., Park, J., Franchi, L., Whitfield, J. R., Barchet, W., Colonna, M., Vandenabeele, P., et al. (2006) · Nature · doi:10.1038/nature04517 · Cited by 1,149
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 832
Lamkanfi, M., & Dixit, V. M. (2017) · Nature · doi:10.1038/548534a · Cited by 70
Self-citationYang, F., Ye, X.-J., Chen, M., Li, H., Wang, Y., Zhong, M.-Y., Zhong, C.-S., Zeng, B., Xu, L., He, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632606 · Cited by 64
Jiao, Y., Nan, J., Mu, B., Zhang, Y., Zhou, N., Yang, S., Zhang, S., Lin, W.-T., Wang, F., Xia, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114194 · Cited by 61
Two non-vesicular ATP release pathways in the mouse erythrocyte membrane
Qiu, F., Wang, J., Spray, D. C., Scemes, E., & Dahl, G. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.09.033 · Cited by 62
Deng, Y., Han, X., Yao, Z. J., Sun, Y., Yu, J., Cai, J., Ren, G., Jiang, G., & Han, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479999 · Cited by 62
Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases
Wu, J., Sun, J., & Meng, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105408 · Cited by 61
The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Artlett, C. M. (2022) · Biomolecules · doi:10.3390/biom12050634 · Cited by 62
Mizushina, Y., Shirasuna, K., Usui, F., Karasawa, T., Kawashima, A., Kimura, H. J., Kobayashi, M., Komada, T., Inoue, Y., Mato, N., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603217 · Cited by 61
Aguilera, M., Darby, T. M., & Melgar, S. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.04.003 · Cited by 60
Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling
Shen, S., Wang, Z., Sun, H., & Ma, L. (2021) · Medical Science Monitor · doi:10.12659/msm.934255 · Cited by 61
Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome
Guo, C., Chen, M., Fa, Z., Lu, A., Fang, W. Y., Sun, B., Chen, C., Liao, W., & Meng, G. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.08.013 · Cited by 58
Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia
Yu, J., Zhu, H., Taheri, S., Mondy, W. L., Bonilha, L., Magwood, G., Lackland, D. T., Adams, R. J., & Kindy, M. S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0801-19.2019 · Cited by 59
Kinra, M., Nampoothiri, M., Arora, D. S., & Mudgal, J. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13124 · Cited by 60
Huang, G., Zhang, Y., Zhang, Y., & Ma, Y. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101417 · Cited by 63
Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1β secretion in human trophoblasts
Tamura, K., Ishikawa, G., Yoshie, M., Ohneda, W., Nakai, A., Takeshita, T., & Tachikawa, E. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.09.032 · Cited by 59
The microbiome and cytosolic innate immune receptors
Liwinski, T., Zheng, D., & Elinav, E. (2020) · Immunological Reviews · doi:10.1111/imr.12901 · Cited by 61
Role of pyroptosis in the pathogenesis and treatment of diseases
Jin, X., Ma, Y., Liu, D., & Huang, Y. (2023) · MedComm · doi:10.1002/mco2.249 · Cited by 61
Regulation of Nlrp3 inflammasome by dietary metabolites
Camell, C. D., Goldberg, E. L., & Dixit, V. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.004 · Cited by 59
Self-citationWei, S., Feng, M. H., & Zhang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416115 · Cited by 60
Stokum, J. A., Shim, B., Negoita, S., Tsymbalyuk, N., Tsymbalyuk, O., Ivanova, S., Keledjian, K. M., Bryan, J., Blaustein, M. P., Jha, R. M., et al. (2023) · Science Signaling · doi:10.1126/scisignal.add6364 · Cited by 60
Abdullaha, M., Mohammed, S., Ali, M., Kumar, A., Vishwakarma, R. A., & Bharate, S. B. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b00138 · Cited by 57
Jorquera, G., Russell‐Guzmán, J., Monsalves‐Álvarez, M., Cruz, G., Valladares-Ide, D., Basualto-Alarcón, C., Barrientos, G. C., Estrada, M., & Llanos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063254 · Cited by 61
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
Chen, C., Zhou, Y., Ning, X., Li, S., Xue, D., Wei, C., Zhu, Z., Sheng, L., Lu, B., Li, Y., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02682-w · Cited by 59
Loss of TLR2 Worsens Spontaneous Colitis in MDR1A Deficiency through Commensally Induced Pyroptosis
Ey, B., Eyking, A., Klepak, M., Salzman, N. H., Göthert, J. R., Rünzi, M., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201592 · Cited by 56
Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
Su, W., Wei, P., Gong, H., Liu, Y., Zhang, Y., Lian, Y., Cao, Z., Wu, R., Liu, L., Wang, B., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0985-4 · Cited by 58
Charan, H. V., Dwivedi, D. K., Khan, S., & Jena, G. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.006 · Cited by 58
Caspases and inflammasomes in metabolic inflammation
Skeldon, A. M., Faraj, M., & Saleh, M. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.5 · Cited by 55
Bononi, A., Napolitano, A., Pass, H. I., Yang, H., & Carbone, M. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1081066 · Cited by 54
Kewcharoenwong, C., Rinchai, D., Utispan, K., Suwannasaen, D., Bancroft, G. J., Ato, M., & Lertmemongkolchai, G. (2013) · Scientific Reports · doi:10.1038/srep03363 · Cited by 53
PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands
Gulati, A., Kaur, D., Prasad, G. V. R. K., & Mukhopadhaya, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3065-0_18 · Cited by 61
Dwivedi, D. K., & Jena, G. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01773-5 · Cited by 54
Çam, M. E., Crabbe‐Mann, M., Alenezi, H., Hazar‐Yavuz, A. N., Ertaş, B., Ekentok, C., Ozcan, G. S., Topal, F., Güler, E., Yazır, Y., et al. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.109844 · Cited by 54
Inflammasome Activation in Chronic Glomerular Diseases
Conley, S. M., Abais, J. M., Boini, K. M., & Li, P. (2016) · Current Drug Targets · doi:10.2174/1389450117666160817103435 · Cited by 53
Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects
Gal, Y., Mazor, O., Falach, R., Sapoznikov, A., Kronman, C., & Sabo, T. (2017) · Toxins · doi:10.3390/toxins9100311 · Cited by 53
Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
Jiang, Q., Wang, X., Huang, E., Wang, Q., Wen, C., Yang, G., Lu, L., & Cui, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816839 · Cited by 55
NLRP10 enhancesShigella-induced pro-inflammatory responses
Lautz, K., Damm, A., Menning, M., Wenger, J., Adam, A. C., Zigrino, P., Kremmer, E., & Kufer, T. A. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01822.x · Cited by 52
Hughes, F. M., Sexton, S. J., Jin, H., Govada, V., & Purves, J. T. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00128.2017 · Cited by 52
Liu, W., Guo, W., Zhu, Y., Peng, S., Zheng, W., Zhang, C., Shao, F., Zhu, Y., Hang, N., Kong, L., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700796 · Cited by 52
Mouasni, S., Gonzalez, V., Schmitt, A., Bennana, E., Guillonneau, F., Mistou, S., Avouac, J., Ea, H., Devauchelle‐Pensec, V., Gottenberg, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1412-9 · Cited by 55
NLRP3 Inflammasome Participates in Host Response to Neospora caninum Infection
Wang, X., Gong, P., Zhang, X., Li, S., Lu, X.-Y., Zhao, C., Yu, Q., Wei, Z., Yang, Y., Liu, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01791 · Cited by 51
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes
Banerjee, T., Calvi, L. M., Becker, M. W., & Liesveld, J. L. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.004 · Cited by 53
Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders
Lahooti, B., Chhibber, T., Bagchi, S., Varahachalam, S. P., & Jayant, R. D. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.004 · Cited by 50
The Role of NLRP3 Inflammasome in Obesity and PCOS—A Systematic Review and Meta-Analysis
Alenezi, S. A., Khan, R. N., Snell, L., Aboeldalyl, S., & Amer, S. A. K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310976 · Cited by 53
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
Ortega, M. A., León-Oliva, D. D., Montero, C. G., Fraile‐Μartinez, O., Boaru, D. L., de Castro, A. V., Sáez, M. A., López-González, L., Buján, J., Álvarez-Mon, M. Á., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1232629 · Cited by 58
The NLRP3 inflammasome, a target for therapy in diverse disease states
Cook, G. P., Savic, S., Wittmann, M., & McDermott, M. (2010) · European Journal of Immunology · doi:10.1002/eji.200940162 · Cited by 51
A clear and present danger: inflammasomes DAMPing down disorders of pregnancy
Khan, R. N., & Hay, D. P. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu059 · Cited by 49
Research progress on the NLRP3 inflammasome and its role in the central nervous system
Liu, S., Mi, W., & Wang, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1328-9 · Cited by 51
The role of NLRP3 inflammasome in stroke and central poststroke pain
Li, S., Zhang, Y., Ma, S., Yi, Y., Yu, H., Pei, L., & Feng, D. (2018) · Medicine · doi:10.1097/md.0000000000011861 · Cited by 50
Liu, H., Gu, C., Liu, M., Liu, G., & Wang, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113998 · Cited by 50
Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
Jiang, C., Xie, S., Yang, G., & Wang, N. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s344730 · Cited by 49
Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety
Chiu, G. S., Darmody, P. T., Walsh, J. P., Moon, M. L., Kwakwa, K. A., Bray, J. K., McCusker, R. H., & Freund, G. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.018 · Cited by 51
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Carvalho, A. M., Novais, F. O., Paixão, C. S., de Oliveira, C. I., Machado, P. R. L., Carvalho, L. P., Scott, P., & Carvalho, E. M. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.025 · Cited by 48
NLRP3: a new therapeutic target in alcoholic liver disease
Brahadeeswaran, S., Dasgupta, T., Manickam, V., Saraswathi, V., & Tamizhselvi, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1215333 · Cited by 51
García-Hernández, M. H., Portales‐Cervantes, L., Cortez-Espinosa, N., Morales, J. M. V., Fritche‐Salazar, J. F., Rivera-López, E., Rodríguez-Rivera, J., Quezada‐Calvillo, R., & Portales‐Pérez, D. P. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.022 · Cited by 48
Scheuermann, U., Zhu, M., Song, M., Yerxa, J., Gao, Q., Davis, R. P., Zhang, M., Parker, W., Hartwig, M. G., Kwun, J., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25429 · Cited by 50
Luo, Y., Long, M., Wu, X., & Zeng, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703560 · Cited by 54
Glyburide Reduces Bacterial Dissemination in a Mouse Model of Melioidosis
Koh, G. C. K. W., Weehuizen, T. A. F., Breitbach, K., Krause, K., de Jong, H. K., Kager, L. M., Hoogendijk, A. J., Bast, A., Peacock, S. J., van der Poll, T., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002500 · Cited by 47
Son, M., Kwak, J. E., Seol, B., Lee, D. Y., Jeon, H., & Cho, Y. S. (2015) · The Journal of Pathology · doi:10.1002/path.4551 · Cited by 47
Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells
Fernandez, M. V., Miller, E., Krammer, F., Gopal, R., Greenbaum, B. D., & Bhardwaj, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-313rrr · Cited by 49
Xing, Y., Cao, R., & Hu, H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.206 · Cited by 47
Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits
Wu, X., Yang, L., Tu, D., Liu, X., Niu, S., Suo, Y., Liu, T., Li, G., & Liu, C. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09965-8 · Cited by 47
Ito, H., Kimura, H. J., Karasawa, T., Hisata, S., Sadatomo, A., Inoue, Y., Yamada, N., Aizawa, E., Hishida, E., Kamata, R., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000217 · Cited by 49
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease
Jha, D., Bakker, E. N. T. P., & Kumar, R. K. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15788 · Cited by 48
The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-κB signaling
Kao, W.-P., Yang, C.-Y., Su, T.-W., Wang, Y.-T., Lo, Y.-C., & Lin, S. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1062-4 · Cited by 45
Sui, X. Y., Yang, J., Zhang, G., Yuan, X., Li, W.-H., Long, J., Luo, Y., Li, Y., & Wang, Y. (2020) · Toxicology · doi:10.1016/j.tox.2020.152392 · Cited by 46
Ye, A., Li, W., Zhou, L., Ao, L., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.009 · Cited by 46
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Vong, C. T., Tseng, H. H. L., Yao, P., Yu, H., Wang, S., Zhong, Z., & Wang, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.018 · Cited by 47
Dwivedi, D. K., & Jena, G. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1540-2 · Cited by 48
Glucose regulates hypoxia‐induced NLRP3 inflammasome activation in macrophages
Watanabe, S., Usui‐Kawanishi, F., Karasawa, T., Kimura, H. J., Kamata, R., Komada, T., Inoue, Y., Mise, N., Kasahara, T., & Takahashi, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29659 · Cited by 46
Effects of Sulfonylureas on Periodontopathic Bacteria-Induced Inflammation
Kawahara, Y., Kaneko, T., Yoshinaga, Y., Arita, Y., Nakamura, K., Koga, C., Yoshimura, A., & Sakagami, R. (2020) · Journal of Dental Research · doi:10.1177/0022034520913250 · Cited by 45
Importance of NLRP3 Inflammasome in Abdominal Aortic Aneurysms
Shi, J., Guo, J., Li, Z., Xu, B., & Miyata, M. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17048 · Cited by 45
Biancatelli, R. M. L. C., Solopov, P. A., & Catravas, J. D. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.003 · Cited by 47
NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners
Leu, S., Tsang, Y.-L., Ho, L., Yang, C.-C., Shao, A., Chang, C.-Y., Lin, H.-K., Tsai, P.-J., Sung, J., & Tsai, Y.-S. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0184 · Cited by 46
Endoplasmic Reticulum Stress Is Increased in Adipose Tissue of Women with Gestational Diabetes
Liong, S., & Lappas, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122633 · Cited by 47
Inflammasome-Mediated Autoinflammatory Disorders
Wilson, S. P., & Cassel, S. L. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2209 · Cited by 44
The Role of NLRP3 Inflammasome in Pneumococcal Infections
Surabhi, S., Cuypers, F., Hammerschmidt, S., & Siemens, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614801 · Cited by 48
The role of inflammasome modulation in virulence
Lupfer, C. R., & Kanneganti, T. (2012) · Virulence · doi:10.4161/viru.20266 · Cited by 43
Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
García‐Martinez, I., Shaker, M. E., & Mehal, W. Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6383 · Cited by 44
Lu, W. L., Song, D., Yue, J., Wang, T. T., Zhou, X., Zhang, P., Zhang, L., & Huang, D. (2016) · International Endodontic Journal · doi:10.1111/iej.12722 · Cited by 43
Inflammatory Changes in Bone Marrow Microenvironment Associated with Declining B Lymphopoiesis
Kennedy, D. E., & Knight, K. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601643 · Cited by 44
Ma, C., Liu, S., Zhang, S., Xu, T., Yu, X. L., Gao, Y., Zhai, C., Li, C., Lei, C., Fan, S., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3911 · Cited by 44
Is immunity a mechanism contributing to statin-induced diabetes?
Henriksbo, B. D., & Schertzer, J. D. (2015) · Adipocyte · doi:10.1080/21623945.2015.1024394 · Cited by 46
Shih, C.-J., Wu, Y.-L., Chao, P.-W., Kuo, S., Yang, C., Li, S., Ou, S., & Chen, Y. (2015) · Scientific Reports · doi:10.1038/srep15260 · Cited by 42
Liu, D., Dong, Z., Xiang, F., Liu, H., Wang, Y., Wang, Q., & Rao, J. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02935-w · Cited by 43
Hou, X., Xu, G., Wang, Z., Zhan, X., Li, H., Li, R., Shi, W., Wang, C., Chen, Y., Ai, Y., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106271 · Cited by 42
Knudsen, S. H., & Pedersen, B. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0642-1 · Cited by 41
Inflammasomes in neurodegenerative diseases
Wang, Q., Yang, S., Zhang, X., Zhang, S., Chen, L., Wang, W., Chen, N., & Yan, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00459-0 · Cited by 47
The role of the inflammasome in cardiovascular diseases
Li, X., Deroide, N., & Mallat, Z. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1144-3 · Cited by 43
Diwan, V., Gobe, G. C., & Brown, L. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.007 · Cited by 41
IL-27 enhances LPS-induced IL-1β in human monocytes and murine macrophages
Petes, C., Wynick, C., Guzzo, C., Mehta, D., Logan, S., Banfield, B. W., Basta, S., Cooper, A. M., & Gee, K. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0316-098r · Cited by 41
Kobayashi, M., Usui‐Kawanishi, F., Karasawa, T., Kimura, H. J., Watanabe, S., Mise, N., Kayama, F., Kasahara, T., Hasebe, N., & Takahashi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176676 · Cited by 41
Tulk, S. E., Liao, K., Muruve, D. A., Li, Y., Beck, P. L., & MacDonald, J. A. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24985 · Cited by 41
A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
Docherty, C. A., Fernando, A. J., Rosli, S., Lam, M., Dolle, R. E., Navia, M. A., Farquhar, R., France, D. L., Tate, M. D., Murphy, C. K., et al. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1455 · Cited by 41
Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue
Fatykhova, D., Rabes, A., Machnik, C., Guruprasad, K., Pache, F. C., Berg, J., Toennies, M., Bauer, T. T., Schneider, P., Schimek, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137108 · Cited by 40
Mihajlovic, M., Krebber, M. M., Yang, Y., Ahmed, S., Lozovanu, V., Andreeva, D., Verhaar, M. C., & Masereeuw, R. (2021) · Biomedicines · doi:10.3390/biomedicines9101326 · Cited by 40
Dutta, D., Liu, J., & Xiong, H. (2022) · PubMed Central · Cited by 38
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
Chen, P., & Li, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1430236 · Cited by 47
Hirota, J. A., Marchant, D., Singhera, G. K., Moheimani, F., Dorscheid, D. R., Carlsten, C., Sin, D. D., & Knight, D. A. (2015) · Experimental Lung Research · doi:10.3109/01902148.2015.1040528 · Cited by 39
Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils
Herman, S., Kny, A., Schorn, C., Pfatschbacher, J., Niederreiter, B., i, M. H., Holmdahl, R., Steiner, G. E., & Hoffmann, M. H. (2012) · Autoimmunity · doi:10.3109/08916934.2012.719948 · Cited by 39
Metadata
- Authors
- Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P., Hoffman, H. M., & Dixit, V. M.
- Affiliations
- Genentech (US)
- University of California San Diego (US)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2009-10-05
- Volume
- 187
- Issue
- 1
- Pages
- 61-70
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2762099
- OpenAlex
- W2134007048
- Cited by
- 820
- References
- 35
- Citations by year
- 2026: 25 · 2025: 44 · 2024: 63 · 2023: 50 · 2022: 67 · 2021: 52 · 2020: 66 · 2019: 64 · 2018: 62 · 2017: 47 · 2016: 42 · 2015: 68 · 2014: 47 · 2013: 44 · 2012: 31
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI052430)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- glibenclamide, NLRP3 inflammasome, NLRP3, caspase-1, IL-1β, IL-18, ATP-sensitive potassium channels, ABC transporters, monocytes, lipopolysaccharide, endotoxemia, gout, type 2 diabetes drugs, inflammasome inhibitors
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adenosine Triphosphatases, Adenosine Triphosphate, Animals, Carrier Proteins, Cells, Cultured, Enzyme Activation, Glyburide, Humans, Hypoglycemic Agents, Inflammation, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Monocytes, Mutation, Random Allocation, Salmonella typhimurium, Mice, Knockout, Caspase 1, Interleukin-18, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review